BioAge Labs (BIOA) Other financing activities (2024 - 2026)

BioAge Labs (BIOA) posted Other financing activities of $91000.0 for Q1 2026, down 72.92% sequentially from $336000.0 in Q4 2025.

BioAge Labs (BIOA) Other financing activities (2024 - 2026) Analysis & Trends

BioAge Labs has reported Other financing activities for 3 years, with the latest figure at $91000.0 in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $91000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $427000.0 (down 99.8% YoY) and the FY2025 annual result came in at $336000.0, down 99.84% from the prior year.
Other financing activities retreated to $91000.0 in Q1 2026 per BIOA's latest filing, from $336000.0 in the prior quarter.
Over five years, Other financing activities peaked at $183.7 million in Q3 2024 and troughed at $3000.0 in Q1 2024.
A 3-year average of $35.4 million and a median of $379000.0 in 2024 frame the typical range for Other financing activities.
The widest YoY moves for Other financing activities: up 98.78% in 2025, down 98.78% in 2025.
Over 3 years, Other financing activities stood at $27.6 million in 2024, then sank by 98.78% to $336000.0 in 2025, then tumbled by 72.92% to $91000.0 in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $91000.0, $336000.0, and $27.6 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	BioAge Labs	434.04 Mn	434.04 Mn	-14.23 Mn

Download Data